期刊
JOURNAL OF MATERIALS CHEMISTRY
卷 22, 期 12, 页码 5770-5783出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c2jm15830b
关键词
-
资金
- Natural Science Foundation Committee of China (NSFC) [81171395, 30672015, 30800257, 81000666, 81071194, 30700779, 30970776, 31050110123]
- Ministry of Science and Technology [2009ZX09310-004]
Stearyl-2-amino-2-deoxyglucose (2-DG) modified nanostructured lipid carriers (NLC) were developed as novel vehicles for tumor-targeted delivery. The NLC were prepared using a melted-ultrasonic method, with glyceryl monostearate (MS) as a solid lipid and oleic acid (OA) as a liquid lipid. The physical properties of the NLC, including particle size, zeta potential, surface morphology, crystal structure, and storage stability, were characterized by standard methods. 2-DG, a glucosamine derivative, serving as a broad tumor targeting ligand, was conjugated to the surface of NLC (2-DG-NLC) for targeted delivery. Fluorescent dyes (fluorescein and cypate) and anticancer drug (paclitaxel, PTX) were used as model drugs to optimize the constituents of the NLC for drug entrapment efficiency and in vitro drug release. The dynamic behavior of 2-DG-NLC in normal mice was investigated with a near infrared (NIR) fluorescence imaging system. The in vitro and in vivo tumor targeting capabilities of 2-DG-NLC were evaluated in MCF-7 tumor cells and tumor bearing mice, respectively. Results demonstrated that 2-DG-NLC actively and efficiently accumulated at the site of the tumor. Paclitaxel encapsulated 2-DG-NLC (2-DG-PTX-NLC) had good antitumor effectiveness and low toxicity in MCF-7 tumor bearing mice. The study indicates the broad potential of this carrier for tumor diagnosis as well as for targeted chemotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据